Can-Fite BioPharma Ltd. (CANF)
$1.93-1.03%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 0.02
- P/E (TTM)
- -0.28
- Short % float
- 6.85%
- Days to cover
- 1.2
- SI change
- -6.3%
- 1W
- -8.10%
- 1M
- -13.84%
- vs SPY 1W
- -7.11%
- vs SPY 1M
- -15.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CANF?
- LOPJLB’s latest quantitative signal on Can-Fite BioPharma Ltd. (CANF) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CANF in?
- Can-Fite BioPharma Ltd. (CANF) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Can-Fite BioPharma Ltd. (CANF) do?
- Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction. Its primary drug candidate, Piclidenoson, has successfully advanced through Phase III clinical trials for psoriasis and co…